Buy or sell NGM Biopharmaceuticals stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

NGM Biopharmaceuticals Stock

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

Founded

2007

Headquarters

South San Francisco CA, US

Total Funding

$295M

About NGM Biopharmaceuticals Stock

NGM Biopharmaceuticals, Inc. is a privately held drug discovery company committed to identifying transformational medicines that dramatically improve human health. Based on emerging human clinical and genetic observations, the Company has devised several innovative experimental approaches to discover new therapies for the treatment of metabolic and cardiovascular diseases. Our current focus is on the gastrointestinal endocrine system, with an aim to identify novel factors implicated in the pathogenesis of type 2 diabetes and the apparent resolution of this grievous disease in patients who have undergone gastric bypass surgery.

Funding History

December 2009$26.6M
November 2011$55.4M
July 2013$50.0M
March 2015$106M
March 2015$57.5M

Management

Vice President, Research

Hui Tian

Vice President, Business Development

Aetna Wun Trombley

Vice President, Clinical Research

Alex DePaoli

Chief Executive Officer

David Woodhouse

Executive Director, Research Operations

Marc Learned

CEO

William J. Rieflin

Vice President CMC and Technical Operations

Chuck Olson

Senior Director, Protein Sciences

Thomas Parsons

CFO

Luis Bayol

Founder, President and Chief Scientific Officer

Jin-Long Chen

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from NGM Biopharmaceuticals or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo